The results demonstrate that a soluble factor in the TME, ADO, plays a pivotal role in the modification of glioma biology directly and through the modulation of the paracrine cross-talk of GBM cells with other cells of the TME such as the BM-MSCs. Here, ADO is linked to central nervous system cancer.